Bemotrizinol: A Major New Advance in Sunscreen Protection Finally Comes to the U.S.
For the first time in more than 20 years, Americans have access to a new sunscreen active ingredient. In June 2026, the U.S. Food and Drug Administration (FDA) added bemotrizinol to the list of permitted sunscreen ingredients—an important development for dermatologists, skincare enthusiasts, and anyone who relies on daily sun protection.
Bemotrizinol has actually been around for years. It has been widely used in sunscreens in Europe, Asia, and other parts of the world, where it is perhaps better known by the trade name Tinosorb S. Its arrival in the United States represents a significant expansion of the sunscreen options available to American consumers.
What Is Bemotrizinol?
Bemotrizinol is a modern, broad-spectrum organic (chemical) UV filter that absorbs both UVA and UVB radiation. It has been used internationally for more than two decades and is known for its strong UV absorption and excellent photostability.
One of its particularly attractive characteristics is its ability to remain stable when exposed to sunlight. Some older chemical sunscreen filters can degrade relatively quickly with UV exposure, while bemotrizinol is highly photostable.
The FDA has authorized bemotrizinol at concentrations of up to 6% in OTC sunscreen products.
Why Is This Such Big News?
You may be wondering: If we already have plenty of sunscreens, why is one new ingredient such a big deal?
The answer is that the U.S. sunscreen market has been unusually restricted compared with Europe and Asia. While newer UV filters have been available internationally for many years, the FDA's list of permitted sunscreen active ingredients had remained largely unchanged since the late 1990s. Bemotrizinol is the first new active ingredient added to the U.S. OTC sunscreen monograph since that time.
That means American sunscreen formulators can now begin developing products using a UV filter that has been available to consumers in other countries for years.
The American Academy of Dermatology Association has called the approval an important public health step because expanding sunscreen options may help encourage more people to use sun protection consistently.
What Makes Bemotrizinol Different?
Excellent broad-spectrum protection: Bemotrizinol absorbs both UVA and UVB wavelengths. This is important because UVB is primarily responsible for sunburn, while UVA contributes significantly to photoaging and also plays a role in skin cancer. Effective sunscreen should provide protection across the UV spectrum—not simply a high SPF number.
Very photostable: One of bemotrizinol's biggest advantages is its photostability. It remains relatively stable when exposed to sunlight, allowing it to maintain its protective properties during UV exposure. This is particularly valuable when developing sunscreen formulations designed for prolonged outdoor exposure.
High efficiency: Bemotrizinol is an efficient UV filter, meaning relatively small amounts can provide substantial UV absorption. This gives formulators more flexibility when creating elegant sunscreen formulations.
Less tendency toward a white cast: Unlike mineral sunscreens containing zinc oxide or titanium dioxide, bemotrizinol is an organic UV filter and does not inherently produce the same visible white residue associated with some mineral formulations. For patients who dislike the appearance or feel of traditional sunscreens, this could be an important advantage.
A long international track record: Perhaps most reassuringly, bemotrizinol isn't an experimental ingredient that suddenly appeared in 2026. It has been used internationally for more than 20 years. The FDA's decision followed a formal review of safety and efficacy data, and the ingredient was added to the U.S. OTC sunscreen monograph as a generally recognized as safe and effective (GRASE) sunscreen active ingredient under specified conditions.
Does This Mean Korean and European Sunscreens Are Now FDA-Approved?
Not necessarily. This is an important distinction.
Many popular European and Korean sunscreens contain bemotrizinol along with other modern UV filters that are still not permitted as sunscreen actives in the United States. For example, some international formulations combine bemotrizinol with ingredients such as bisoctrizole and other newer-generation filters that remain outside the U.S. sunscreen monograph.
So the FDA approval of bemotrizinol does not mean that every European or Korean sunscreen containing it is suddenly approved for sale in the United States. Instead, American manufacturers can now formulate new products using bemotrizinol while complying with U.S. sunscreen regulations.
When Will We See Bemotrizinol Sunscreens in the U.S.?
The FDA's final order became effective August 9, 2026, and manufacturers can now incorporate bemotrizinol into compliant U.S. sunscreen products. The first products are expected to begin appearing in the U.S. market during the latter part of 2026 and into 2027 as manufacturers complete formulation, testing, regulatory, and manufacturing requirements.
In other words, the FDA approval is here—but widespread availability on store shelves will take some time.
Is Bemotrizinol "Better" Than Mineral Sunscreen?
Not necessarily. There is no single sunscreen ingredient that is best for everyone.
Zinc oxide, for example, remains an excellent sunscreen active ingredient with broad-spectrum protection and an outstanding safety record. Mineral sunscreens can be particularly useful for people with sensitive skin or certain preferences regarding sunscreen ingredients.
Bemotrizinol simply gives dermatologists and consumers another excellent tool. The most effective sunscreen is ultimately the one you will apply generously and consistently.
What About SPF?
It's important not to confuse the introduction of bemotrizinol with a new definition of SPF.
SPF primarily measures protection against UVB-induced sunburn. It does not tell the whole story about UVA protection or protection against long-term photoaging.
When selecting sunscreen, I recommend looking for:
Broad-spectrum protection
SPF 30 or higher
A formulation you enjoy using
Water resistance when appropriate
Consistent, generous application
Reapplication when spending extended time outdoors
Bemotrizinol may make it easier for manufacturers to create sunscreens that provide excellent protection while maintaining a cosmetically elegant texture—something that can ultimately improve sunscreen adherence.
What Does This Mean for Patients?
As a dermatologist, I'm particularly excited about this development because better sunscreen technology can translate into better sunscreen use.
Many patients don't avoid sunscreen because they don't understand its importance. They avoid it because they dislike the way it feels, looks, or wears under makeup. Newer-generation filters such as bemotrizinol have the potential to produce sunscreens that are lighter, more elegant, and more enjoyable to use while providing excellent broad-spectrum UV protection.
And when patients actually enjoy using their sunscreen, they are much more likely to use it every day.
The Bottom Line
The FDA approval of bemotrizinol is one of the most significant developments in American sunscreen technology in decades. It doesn't make existing sunscreens obsolete, and it doesn't mean that every international sunscreen is suddenly FDA-approved. But it does open the door to a new generation of sunscreen formulations that have been available to consumers overseas for many years.
For the first time in more than two decades, American sunscreen formulators have a genuinely new UV filter to work with. That's very good news for skin health.
As these products become available, your dermatologist can help you determine which sunscreen formulation—and which combination of UV filters—is best suited to your skin, lifestyle, and level of sun exposure.
Comments